Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Newsletter out

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 27, 2021 8:01am

198 Views

Post# 33072883

RE:RE:Newsletter out

Also concentrating on those 6 Oilminer and it is impossible for the 3 pending who dilute the % of success through their (bizarre IMHO) inclusion to register any positive outcome. At present they are very likely skewing the impression to an overly-negative one.

The Trial needs to run a while yet before meaningful conclusions can be drawn.

Here and have been for the last 7 years` for Rutherrin and if it is truly going into humans with radio activation next year here I will remain but on the strength of this they will likely need to raise cash again beforehand.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario